Astragaloside IV attenuates experimental autoimmune encephalomyelitis of mice by counteracting oxidative stress at multiple levels Y He, M Du, Y Gao, H Liu, H Wang, X Wu, Z Wang PloS one 8 (10), e76495, 2013 | 95 | 2013 |
Platelet P2Y12 receptors are involved in the haemostatic effect of notoginsenoside Ft1, a saponin isolated from Panax notoginseng B Gao, L Huang, H Liu, H Wu, E Zhang, L Yang, X Wu, Z Wang British journal of pharmacology 171 (1), 214-223, 2014 | 71 | 2014 |
An RNA-targeting CRISPR–Cas13d system alleviates disease-related phenotypes in Huntington’s disease models KH Morelli, Q Wu, ML Gosztyla, H Liu, M Yao, C Zhang, J Chen, ... Nature neuroscience 26 (1), 27-38, 2023 | 64 | 2023 |
Astragaloside IV inhibits microglia activation via glucocorticoid receptor mediated signaling pathway HS Liu, HL Shi, F Huang, KE Peterson, H Wu, YY Lan, BB Zhang, YX He, ... Scientific Reports 6 (1), 19137, 2016 | 64 | 2016 |
Huntingtin silencing delays onset and slows progression of Huntington’s disease: a biomarker study H Liu, C Zhang, J Xu, J Jin, L Cheng, X Miao, Q Wu, Z Wei, P Liu, H Lu, ... Brain 144 (10), 3101-3113, 2021 | 37 | 2021 |
Astragalosides from Radix Astragali benefits experimental autoimmune encephalomyelitis in C57BL/6 mice at multiple levels YX He, M Du, HL Shi, F Huang, HS Liu, H Wu, BB Zhang, W Dou, XJ Wu, ... BMC Complementary and Alternative Medicine 14, 1-11, 2014 | 27 | 2014 |
Abnormal brain development in Huntington’disease is recapitulated in the zQ175 knock-in mouse model C Zhang, Q Wu, H Liu, L Cheng, Z Hou, S Mori, J Hua, CA Ross, J Zhang, ... Cerebral Cortex Communications 1 (1), tgaa044, 2020 | 21 | 2020 |
Isoastragaloside I inhibits NF-κB activation and inflammatory responses in BV-2 microglial cells stimulated with lipopolysaccharide H Liu, F Huang, H Wu, B Zhang, H Shi, X Wu, Z Hu International journal of molecular medicine 40 (4), 1270-1276, 2017 | 18 | 2017 |
Non-contrast assessment of blood-brain barrier permeability to water in mice: An arterial spin labeling study at cerebral veins Z Wei, H Liu, Z Lin, M Yao, R Li, C Liu, Y Li, J Xu, W Duan, H Lu Neuroimage 268, 119870, 2023 | 16 | 2023 |
Nemo-like kinase reduces mutant huntingtin levels and mitigates Huntington’s disease M Jiang, X Zhang, H Liu, J LeBron, A Alexandris, Q Peng, H Gu, F Yang, ... Human molecular genetics 29 (8), 1340-1352, 2020 | 16 | 2020 |
Age‐dependent cerebrospinal fluid‐tissue water exchange detected by magnetization transfer indirect spin labeling MRI AM Li, L Chen, H Liu, Y Li, W Duan, J Xu Magnetic resonance in medicine 87 (5), 2287-2298, 2022 | 9 | 2022 |
Interrogation of dynamic glucose-enhanced MRI and fluorescence-based imaging reveals a perturbed glymphatic network in Huntington’s disease H Liu, L Chen, C Zhang, C Liu, Y Li, L Cheng, Z Wei, Z Zhang, H Lu, ... bioRxiv, 2023.04. 03.535397, 2023 | 5 | 2023 |
Glymphatic influx and clearance are perturbed in Huntington’s disease H Liu, L Chen, C Zhang, C Liu, Y Li, L Cheng, Y Ouyang, C Rutledge, ... JCI insight 9 (20), e172286, 2024 | 3 | 2024 |
HTT silencing delays onset and slows progression of Huntington’s disease like phenotype: Monitoring with a novel neurovascular biomarker H Liu, C Zhang, J Xu, J Jin, L Cheng, Q Wu, Z Wei, P Liu, H Lu, ... bioRxiv, 2020.11. 17.386631, 2020 | 3 | 2020 |
Roscovitine, a CDK inhibitor, reduced neuronal toxicity of mHTT by targeting HTT phosphorylation at S1181 and S1201 in Vitro H Liu, A McCollum, A Krishnaprakash, Y Ouyang, T Shi, T Ratovitski, ... International journal of molecular sciences 25 (22), 12315, 2024 | 2 | 2024 |
RNA-Targeting CRISPR/Cas13d system eliminates disease-related phenotypes in pre-clinical models of huntington’s disease KH Morelli, Q Wu, ML Gosztyla, H Liu, C Zhang, J Chen, R Marina, K Lee, ... Biorxiv, 2022.01. 23.477417, 2022 | 2 | 2022 |
Mutant G2019S-LRRK2 Induces Abnormalities in Arteriolar Cerebral Blood Volume in Mouse Brains: An MRI Study B Ning, G Guo, C Gu, J Xu, A Bibic, X He, H Liu, L Chen, Z Wei, W Duan, ... Neurodegenerative Diseases 20 (2-3), 65-72, 2020 | 2 | 2020 |